nodes	percent_of_prediction	percent_of_DWPC	metapath
Apomorphine—CALY—malignant glioma	0.848	1	CbGaD
Apomorphine—HTR1D—meninx—malignant glioma	0.0104	0.0958	CbGeAlD
Apomorphine—HTR1B—dura mater—malignant glioma	0.00987	0.091	CbGeAlD
Apomorphine—HTR1D—dura mater—malignant glioma	0.00955	0.0882	CbGeAlD
Apomorphine—HTR2C—choroid plexus—malignant glioma	0.00804	0.0742	CbGeAlD
Apomorphine—DRD3—telencephalic ventricle—malignant glioma	0.00424	0.0391	CbGeAlD
Apomorphine—HTR2A—choroid plexus—malignant glioma	0.00403	0.0372	CbGeAlD
Apomorphine—DRD1—telencephalic ventricle—malignant glioma	0.00303	0.028	CbGeAlD
Apomorphine—HTR1B—telencephalic ventricle—malignant glioma	0.00246	0.0227	CbGeAlD
Apomorphine—HTR1D—telencephalic ventricle—malignant glioma	0.00238	0.022	CbGeAlD
Apomorphine—HTR2C—telencephalic ventricle—malignant glioma	0.00236	0.0217	CbGeAlD
Apomorphine—HTR2A—cerebellar cortex—malignant glioma	0.00203	0.0188	CbGeAlD
Apomorphine—HTR1A—telencephalic ventricle—malignant glioma	0.00198	0.0183	CbGeAlD
Apomorphine—CALY—telencephalon—malignant glioma	0.00188	0.0174	CbGeAlD
Apomorphine—DRD2—telencephalic ventricle—malignant glioma	0.00179	0.0165	CbGeAlD
Apomorphine—CALY—medulla oblongata—malignant glioma	0.00148	0.0137	CbGeAlD
Apomorphine—HTR2A—pons—malignant glioma	0.00144	0.0133	CbGeAlD
Apomorphine—HTR2A—vertebral column—malignant glioma	0.00143	0.0132	CbGeAlD
Apomorphine—CALY—midbrain—malignant glioma	0.00135	0.0125	CbGeAlD
Apomorphine—CALY—spinal cord—malignant glioma	0.00132	0.0122	CbGeAlD
Apomorphine—HTR1B—blood vessel—malignant glioma	0.00122	0.0112	CbGeAlD
Apomorphine—HTR2A—telencephalic ventricle—malignant glioma	0.00118	0.0109	CbGeAlD
Apomorphine—HTR1D—blood vessel—malignant glioma	0.00118	0.0109	CbGeAlD
Apomorphine—CALY—central nervous system—malignant glioma	0.00107	0.00988	CbGeAlD
Apomorphine—CALY—cerebellum—malignant glioma	0.00105	0.00966	CbGeAlD
Apomorphine—HTR2A—pineal body—malignant glioma	0.00103	0.00946	CbGeAlD
Apomorphine—DRD5—telencephalon—malignant glioma	0.000953	0.0088	CbGeAlD
Apomorphine—CALY—brain—malignant glioma	0.00085	0.00784	CbGeAlD
Apomorphine—DRD1—brainstem—malignant glioma	0.000821	0.00757	CbGeAlD
Apomorphine—ADRA1D—telencephalon—malignant glioma	0.000764	0.00705	CbGeAlD
Apomorphine—DRD1—telencephalon—malignant glioma	0.000728	0.00672	CbGeAlD
Apomorphine—HTR1B—brainstem—malignant glioma	0.000665	0.00614	CbGeAlD
Apomorphine—DRD4—brain—malignant glioma	0.000653	0.00603	CbGeAlD
Apomorphine—HTR1D—brainstem—malignant glioma	0.000644	0.00594	CbGeAlD
Apomorphine—HTR2C—brainstem—malignant glioma	0.000638	0.00588	CbGeAlD
Apomorphine—HTR2A—endothelium—malignant glioma	0.000634	0.00585	CbGeAlD
Apomorphine—HTR1B—telencephalon—malignant glioma	0.00059	0.00545	CbGeAlD
Apomorphine—HTR2A—blood vessel—malignant glioma	0.000585	0.0054	CbGeAlD
Apomorphine—DRD3—central nervous system—malignant glioma	0.000578	0.00534	CbGeAlD
Apomorphine—HTR1D—telencephalon—malignant glioma	0.000571	0.00527	CbGeAlD
Apomorphine—HTR2C—telencephalon—malignant glioma	0.000566	0.00522	CbGeAlD
Apomorphine—DRD5—central nervous system—malignant glioma	0.000542	0.005	CbGeAlD
Apomorphine—HTR1A—brainstem—malignant glioma	0.000537	0.00495	CbGeAlD
Apomorphine—HTR2B—telencephalon—malignant glioma	0.000531	0.0049	CbGeAlD
Apomorphine—DRD1—midbrain—malignant glioma	0.000523	0.00483	CbGeAlD
Apomorphine—DRD2—brainstem—malignant glioma	0.000485	0.00447	CbGeAlD
Apomorphine—HTR1A—telencephalon—malignant glioma	0.000476	0.00439	CbGeAlD
Apomorphine—DRD2—retina—malignant glioma	0.000468	0.00432	CbGeAlD
Apomorphine—DRD3—brain—malignant glioma	0.000459	0.00424	CbGeAlD
Apomorphine—HTR2C—medulla oblongata—malignant glioma	0.000445	0.0041	CbGeAlD
Apomorphine—ADRA1B—central nervous system—malignant glioma	0.000444	0.0041	CbGeAlD
Apomorphine—ADRA1D—central nervous system—malignant glioma	0.000434	0.00401	CbGeAlD
Apomorphine—DRD2—telencephalon—malignant glioma	0.00043	0.00397	CbGeAlD
Apomorphine—DRD5—brain—malignant glioma	0.00043	0.00397	CbGeAlD
Apomorphine—HTR1B—midbrain—malignant glioma	0.000424	0.00391	CbGeAlD
Apomorphine—ADRA2C—telencephalon—malignant glioma	0.000418	0.00386	CbGeAlD
Apomorphine—DRD1—central nervous system—malignant glioma	0.000414	0.00382	CbGeAlD
Apomorphine—HTR1B—spinal cord—malignant glioma	0.000413	0.00382	CbGeAlD
Apomorphine—HTR1D—midbrain—malignant glioma	0.00041	0.00379	CbGeAlD
Apomorphine—HTR2C—midbrain—malignant glioma	0.000406	0.00375	CbGeAlD
Apomorphine—HTR2C—spinal cord—malignant glioma	0.000396	0.00366	CbGeAlD
Apomorphine—ADRA1B—brain—malignant glioma	0.000353	0.00325	CbGeAlD
Apomorphine—HTR2A—embryo—malignant glioma	0.000349	0.00322	CbGeAlD
Apomorphine—ADRA1D—brain—malignant glioma	0.000345	0.00318	CbGeAlD
Apomorphine—HTR1A—midbrain—malignant glioma	0.000342	0.00316	CbGeAlD
Apomorphine—HTR1B—central nervous system—malignant glioma	0.000335	0.0031	CbGeAlD
Apomorphine—ADRA2A—telencephalon—malignant glioma	0.000334	0.00308	CbGeAlD
Apomorphine—HTR1A—spinal cord—malignant glioma	0.000334	0.00308	CbGeAlD
Apomorphine—ADRA2C—medulla oblongata—malignant glioma	0.000329	0.00303	CbGeAlD
Apomorphine—DRD1—brain—malignant glioma	0.000329	0.00303	CbGeAlD
Apomorphine—HTR1D—central nervous system—malignant glioma	0.000325	0.003	CbGeAlD
Apomorphine—HTR2C—central nervous system—malignant glioma	0.000322	0.00297	CbGeAlD
Apomorphine—HTR2A—brainstem—malignant glioma	0.00032	0.00295	CbGeAlD
Apomorphine—DRD2—midbrain—malignant glioma	0.000309	0.00285	CbGeAlD
Apomorphine—HTR2A—retina—malignant glioma	0.000309	0.00285	CbGeAlD
Apomorphine—HTR2B—central nervous system—malignant glioma	0.000302	0.00279	CbGeAlD
Apomorphine—ADRA2C—midbrain—malignant glioma	0.0003	0.00277	CbGeAlD
Apomorphine—ADRA2C—spinal cord—malignant glioma	0.000293	0.0027	CbGeAlD
Apomorphine—HTR2A—telencephalon—malignant glioma	0.000284	0.00262	CbGeAlD
Apomorphine—HTR1A—central nervous system—malignant glioma	0.000271	0.0025	CbGeAlD
Apomorphine—HTR1B—brain—malignant glioma	0.000266	0.00246	CbGeAlD
Apomorphine—HTR1A—cerebellum—malignant glioma	0.000265	0.00244	CbGeAlD
Apomorphine—ADRA2A—medulla oblongata—malignant glioma	0.000262	0.00242	CbGeAlD
Apomorphine—Injection site reaction—Carmustine—malignant glioma	0.000258	0.0514	CcSEcCtD
Apomorphine—HTR1D—brain—malignant glioma	0.000258	0.00238	CbGeAlD
Apomorphine—HTR2C—brain—malignant glioma	0.000255	0.00236	CbGeAlD
Apomorphine—DRD2—central nervous system—malignant glioma	0.000245	0.00226	CbGeAlD
Apomorphine—HTR2B—brain—malignant glioma	0.00024	0.00221	CbGeAlD
Apomorphine—ADRA2A—midbrain—malignant glioma	0.00024	0.00221	CbGeAlD
Apomorphine—DRD2—cerebellum—malignant glioma	0.000239	0.00221	CbGeAlD
Apomorphine—ADRA2C—central nervous system—malignant glioma	0.000238	0.00219	CbGeAlD
Apomorphine—ADRA2A—spinal cord—malignant glioma	0.000234	0.00216	CbGeAlD
Apomorphine—ADRA2C—cerebellum—malignant glioma	0.000232	0.00214	CbGeAlD
Apomorphine—HTR2A—medulla oblongata—malignant glioma	0.000223	0.00206	CbGeAlD
Apomorphine—HTR1A—brain—malignant glioma	0.000215	0.00198	CbGeAlD
Apomorphine—Swelling—Carmustine—malignant glioma	0.000214	0.0425	CcSEcCtD
Apomorphine—HTR2A—midbrain—malignant glioma	0.000204	0.00188	CbGeAlD
Apomorphine—HTR2A—spinal cord—malignant glioma	0.000199	0.00184	CbGeAlD
Apomorphine—DRD2—brain—malignant glioma	0.000194	0.00179	CbGeAlD
Apomorphine—ADRA2A—central nervous system—malignant glioma	0.00019	0.00175	CbGeAlD
Apomorphine—ADRA2C—brain—malignant glioma	0.000189	0.00174	CbGeAlD
Apomorphine—ADRA2A—cerebellum—malignant glioma	0.000185	0.00171	CbGeAlD
Apomorphine—Dehydration—Temozolomide—malignant glioma	0.000169	0.0337	CcSEcCtD
Apomorphine—HTR2A—central nervous system—malignant glioma	0.000161	0.00149	CbGeAlD
Apomorphine—HTR2A—cerebellum—malignant glioma	0.000158	0.00146	CbGeAlD
Apomorphine—Sweating increased—Temozolomide—malignant glioma	0.000153	0.0305	CcSEcCtD
Apomorphine—ADRA2A—brain—malignant glioma	0.000151	0.00139	CbGeAlD
Apomorphine—Pneumonia—Carmustine—malignant glioma	0.000146	0.0291	CcSEcCtD
Apomorphine—Urinary tract infection—Carmustine—malignant glioma	0.000141	0.0281	CcSEcCtD
Apomorphine—Pneumonia—Temozolomide—malignant glioma	0.000141	0.0281	CcSEcCtD
Apomorphine—Urinary tract infection—Temozolomide—malignant glioma	0.000136	0.0271	CcSEcCtD
Apomorphine—Hallucination—Carmustine—malignant glioma	0.00013	0.0258	CcSEcCtD
Apomorphine—HTR2A—brain—malignant glioma	0.000128	0.00118	CbGeAlD
Apomorphine—Hallucination—Temozolomide—malignant glioma	0.000125	0.0249	CcSEcCtD
Apomorphine—Flushing—Carmustine—malignant glioma	0.000121	0.0241	CcSEcCtD
Apomorphine—Flushing—Temozolomide—malignant glioma	0.000117	0.0233	CcSEcCtD
Apomorphine—Mental disorder—Carmustine—malignant glioma	0.000114	0.0227	CcSEcCtD
Apomorphine—Mental disorder—Temozolomide—malignant glioma	0.00011	0.022	CcSEcCtD
Apomorphine—Back pain—Carmustine—malignant glioma	0.00011	0.0218	CcSEcCtD
Apomorphine—Back pain—Temozolomide—malignant glioma	0.000106	0.0211	CcSEcCtD
Apomorphine—Chest pain—Carmustine—malignant glioma	9.66e-05	0.0192	CcSEcCtD
Apomorphine—Anxiety—Carmustine—malignant glioma	9.63e-05	0.0192	CcSEcCtD
Apomorphine—Confusional state—Carmustine—malignant glioma	9.34e-05	0.0186	CcSEcCtD
Apomorphine—Arthralgia—Temozolomide—malignant glioma	9.33e-05	0.0186	CcSEcCtD
Apomorphine—Anxiety—Temozolomide—malignant glioma	9.3e-05	0.0185	CcSEcCtD
Apomorphine—Oedema—Carmustine—malignant glioma	9.26e-05	0.0184	CcSEcCtD
Apomorphine—Confusional state—Temozolomide—malignant glioma	9.02e-05	0.018	CcSEcCtD
Apomorphine—Oedema—Temozolomide—malignant glioma	8.95e-05	0.0178	CcSEcCtD
Apomorphine—Hypotension—Carmustine—malignant glioma	8.65e-05	0.0172	CcSEcCtD
Apomorphine—Hyperhidrosis—Temozolomide—malignant glioma	8.65e-05	0.0172	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Carmustine—malignant glioma	8.44e-05	0.0168	CcSEcCtD
Apomorphine—Insomnia—Carmustine—malignant glioma	8.38e-05	0.0167	CcSEcCtD
Apomorphine—Dyspnoea—Carmustine—malignant glioma	8.26e-05	0.0164	CcSEcCtD
Apomorphine—Somnolence—Carmustine—malignant glioma	8.23e-05	0.0164	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Temozolomide—malignant glioma	8.15e-05	0.0162	CcSEcCtD
Apomorphine—Insomnia—Temozolomide—malignant glioma	8.09e-05	0.0161	CcSEcCtD
Apomorphine—Dyspnoea—Temozolomide—malignant glioma	7.98e-05	0.0159	CcSEcCtD
Apomorphine—Somnolence—Temozolomide—malignant glioma	7.96e-05	0.0158	CcSEcCtD
Apomorphine—Constipation—Carmustine—malignant glioma	7.92e-05	0.0158	CcSEcCtD
Apomorphine—Fatigue—Temozolomide—malignant glioma	7.72e-05	0.0154	CcSEcCtD
Apomorphine—Constipation—Temozolomide—malignant glioma	7.65e-05	0.0152	CcSEcCtD
Apomorphine—Feeling abnormal—Carmustine—malignant glioma	7.63e-05	0.0152	CcSEcCtD
Apomorphine—Feeling abnormal—Temozolomide—malignant glioma	7.37e-05	0.0147	CcSEcCtD
Apomorphine—Asthenia—Carmustine—malignant glioma	6.64e-05	0.0132	CcSEcCtD
Apomorphine—Asthenia—Temozolomide—malignant glioma	6.42e-05	0.0128	CcSEcCtD
Apomorphine—Diarrhoea—Carmustine—malignant glioma	6.34e-05	0.0126	CcSEcCtD
Apomorphine—Pruritus—Temozolomide—malignant glioma	6.33e-05	0.0126	CcSEcCtD
Apomorphine—Dizziness—Carmustine—malignant glioma	6.12e-05	0.0122	CcSEcCtD
Apomorphine—Diarrhoea—Temozolomide—malignant glioma	6.12e-05	0.0122	CcSEcCtD
Apomorphine—Dizziness—Temozolomide—malignant glioma	5.92e-05	0.0118	CcSEcCtD
Apomorphine—Vomiting—Carmustine—malignant glioma	5.89e-05	0.0117	CcSEcCtD
Apomorphine—Headache—Carmustine—malignant glioma	5.8e-05	0.0115	CcSEcCtD
Apomorphine—Vomiting—Temozolomide—malignant glioma	5.69e-05	0.0113	CcSEcCtD
Apomorphine—Headache—Temozolomide—malignant glioma	5.61e-05	0.0112	CcSEcCtD
Apomorphine—Nausea—Carmustine—malignant glioma	5.5e-05	0.0109	CcSEcCtD
Apomorphine—Nausea—Temozolomide—malignant glioma	5.32e-05	0.0106	CcSEcCtD
Apomorphine—DRD5—Signaling Pathways—TP53—malignant glioma	3.86e-06	9.95e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—PIK3CA—malignant glioma	3.86e-06	9.95e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—AKT2—malignant glioma	3.86e-06	9.94e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MDM2—malignant glioma	3.85e-06	9.91e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CD80—malignant glioma	3.85e-06	9.9e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—EGFR—malignant glioma	3.84e-06	9.9e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—PIK3CA—malignant glioma	3.84e-06	9.9e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—APC—malignant glioma	3.84e-06	9.89e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PIK3CG—malignant glioma	3.84e-06	9.89e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—VEGFA—malignant glioma	3.83e-06	9.88e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—RAF1—malignant glioma	3.83e-06	9.87e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MDM2—malignant glioma	3.83e-06	9.86e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—RAF1—malignant glioma	3.81e-06	9.82e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—STAT3—malignant glioma	3.8e-06	9.78e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—EGF—malignant glioma	3.79e-06	9.77e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—ERBB2—malignant glioma	3.79e-06	9.77e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—MMP9—malignant glioma	3.78e-06	9.74e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—VEGFA—malignant glioma	3.77e-06	9.72e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—ERBB2—malignant glioma	3.77e-06	9.72e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PTPN11—malignant glioma	3.77e-06	9.71e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—PIK3CD—malignant glioma	3.77e-06	9.71e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—PTEN—malignant glioma	3.76e-06	9.69e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—PIK3CB—malignant glioma	3.74e-06	9.64e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—PTEN—malignant glioma	3.74e-06	9.64e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—PIK3CA—malignant glioma	3.74e-06	9.62e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—STAT3—malignant glioma	3.74e-06	9.62e-05	CbGpPWpGaD
Apomorphine—DRD2—GPCR downstream signaling—PIK3CA—malignant glioma	3.73e-06	9.62e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—MMP9—malignant glioma	3.73e-06	9.61e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—MMP9—malignant glioma	3.73e-06	9.61e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CXCL8—malignant glioma	3.72e-06	9.59e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—PIK3CB—malignant glioma	3.72e-06	9.59e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MDM2—malignant glioma	3.72e-06	9.59e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—PTEN—malignant glioma	3.71e-06	9.56e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—PTEN—malignant glioma	3.71e-06	9.56e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—PIK3CD—malignant glioma	3.71e-06	9.55e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—RAF1—malignant glioma	3.71e-06	9.55e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—KRAS—malignant glioma	3.69e-06	9.51e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—PIK3CA—malignant glioma	3.68e-06	9.47e-05	CbGpPWpGaD
Apomorphine—HTR2A—GPCR downstream signaling—PIK3CA—malignant glioma	3.67e-06	9.46e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—ERBB2—malignant glioma	3.67e-06	9.45e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—AKT1—malignant glioma	3.67e-06	9.45e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MDM2—malignant glioma	3.66e-06	9.43e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—RAF1—malignant glioma	3.65e-06	9.4e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—KRAS—malignant glioma	3.63e-06	9.35e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—PIK3CB—malignant glioma	3.62e-06	9.33e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—AKT1—malignant glioma	3.62e-06	9.32e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—AKT1—malignant glioma	3.62e-06	9.32e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—ERBB2—malignant glioma	3.61e-06	9.3e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—FGF2—malignant glioma	3.61e-06	9.3e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—BRAF—malignant glioma	3.61e-06	9.29e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—MYC—malignant glioma	3.6e-06	9.28e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—VEGFA—malignant glioma	3.6e-06	9.28e-05	CbGpPWpGaD
Apomorphine—ADRA2B—GPCR downstream signaling—AKT1—malignant glioma	3.6e-06	9.27e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CXCL8—malignant glioma	3.6e-06	9.26e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CXCL8—malignant glioma	3.58e-06	9.21e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—STAT3—malignant glioma	3.57e-06	9.19e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CASP3—malignant glioma	3.57e-06	9.18e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—PIK3CB—malignant glioma	3.56e-06	9.18e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—IL2—malignant glioma	3.56e-06	9.17e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—FGF2—malignant glioma	3.55e-06	9.15e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—MYC—malignant glioma	3.53e-06	9.09e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—EGFR—malignant glioma	3.52e-06	9.08e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PIK3CB—malignant glioma	3.52e-06	9.06e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—AKT2—malignant glioma	3.51e-06	9.05e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—EGFR—malignant glioma	3.5e-06	9.01e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PTGS2—malignant glioma	3.48e-06	8.98e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CXCL8—malignant glioma	3.48e-06	8.96e-05	CbGpPWpGaD
Apomorphine—HTR1A—GPCR downstream signaling—AKT1—malignant glioma	3.47e-06	8.95e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—MYC—malignant glioma	3.47e-06	8.94e-05	CbGpPWpGaD
Apomorphine—HTR2C—GPCR downstream signaling—AKT1—malignant glioma	3.46e-06	8.9e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—EGFR—malignant glioma	3.45e-06	8.89e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CASP3—malignant glioma	3.44e-06	8.87e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—IL2—malignant glioma	3.44e-06	8.85e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CXCL8—malignant glioma	3.42e-06	8.82e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CASP3—malignant glioma	3.42e-06	8.82e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—IL2—malignant glioma	3.42e-06	8.81e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—VEGFA—malignant glioma	3.4e-06	8.75e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—EGFR—malignant glioma	3.4e-06	8.75e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	3.39e-06	8.73e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MDM2—malignant glioma	3.38e-06	8.7e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PIK3CD—malignant glioma	3.37e-06	8.69e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MMP9—malignant glioma	3.37e-06	8.68e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—RAF1—malignant glioma	3.36e-06	8.67e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—STAT3—malignant glioma	3.36e-06	8.66e-05	CbGpPWpGaD
Apomorphine—ADRA2C—GPCR downstream signaling—AKT1—malignant glioma	3.36e-06	8.66e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—VEGFA—malignant glioma	3.35e-06	8.63e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—VEGFA—malignant glioma	3.35e-06	8.63e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—PTEN—malignant glioma	3.35e-06	8.63e-05	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—PIK3CA—malignant glioma	3.34e-06	8.61e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—PIK3CA—malignant glioma	3.34e-06	8.59e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CASP3—malignant glioma	3.33e-06	8.58e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—ERBB2—malignant glioma	3.33e-06	8.58e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—KRAS—malignant glioma	3.33e-06	8.57e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IL2—malignant glioma	3.33e-06	8.57e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MDM2—malignant glioma	3.32e-06	8.56e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—STAT3—malignant glioma	3.32e-06	8.55e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—STAT3—malignant glioma	3.32e-06	8.55e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—MYC—malignant glioma	3.31e-06	8.54e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—RAF1—malignant glioma	3.31e-06	8.53e-05	CbGpPWpGaD
Apomorphine—ADRA1B—GPCR downstream signaling—AKT1—malignant glioma	3.31e-06	8.52e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—KRAS—malignant glioma	3.3e-06	8.51e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—PIK3CB—malignant glioma	3.29e-06	8.46e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CASP3—malignant glioma	3.28e-06	8.44e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—ERBB2—malignant glioma	3.28e-06	8.44e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IL2—malignant glioma	3.27e-06	8.43e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—AKT1—malignant glioma	3.27e-06	8.42e-05	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—AKT1—malignant glioma	3.26e-06	8.4e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—KRAS—malignant glioma	3.26e-06	8.4e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MMP9—malignant glioma	3.25e-06	8.38e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—EGFR—malignant glioma	3.24e-06	8.35e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MMP9—malignant glioma	3.24e-06	8.33e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—PTEN—malignant glioma	3.23e-06	8.33e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—PIK3CB—malignant glioma	3.23e-06	8.33e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—FGF2—malignant glioma	3.23e-06	8.32e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—PTEN—malignant glioma	3.22e-06	8.29e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—KRAS—malignant glioma	3.21e-06	8.26e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CXCL8—malignant glioma	3.16e-06	8.13e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—AKT1—malignant glioma	3.15e-06	8.13e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MMP9—malignant glioma	3.15e-06	8.11e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—AKT1—malignant glioma	3.14e-06	8.08e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—PTEN—malignant glioma	3.13e-06	8.06e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—MYC—malignant glioma	3.12e-06	8.05e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CXCL8—malignant glioma	3.11e-06	8e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MMP9—malignant glioma	3.1e-06	7.98e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—MYC—malignant glioma	3.08e-06	7.94e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—MYC—malignant glioma	3.08e-06	7.94e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—PTEN—malignant glioma	3.08e-06	7.93e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—KRAS—malignant glioma	3.06e-06	7.89e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—PIK3CA—malignant glioma	3.06e-06	7.88e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—EGFR—malignant glioma	3.06e-06	7.87e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—AKT1—malignant glioma	3.05e-06	7.86e-05	CbGpPWpGaD
Apomorphine—DRD2—GPCR downstream signaling—AKT1—malignant glioma	3.05e-06	7.86e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PTEN—malignant glioma	3.04e-06	7.83e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	3.03e-06	7.82e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—VEGFA—malignant glioma	3.03e-06	7.79e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MDM2—malignant glioma	3.02e-06	7.79e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CASP3—malignant glioma	3.02e-06	7.78e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IL2—malignant glioma	3.02e-06	7.77e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—EGFR—malignant glioma	3.02e-06	7.77e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—EGFR—malignant glioma	3.02e-06	7.77e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—RAF1—malignant glioma	3.01e-06	7.76e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—AKT1—malignant glioma	3e-06	7.74e-05	CbGpPWpGaD
Apomorphine—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	3e-06	7.73e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—STAT3—malignant glioma	3e-06	7.72e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—PIK3CA—malignant glioma	2.99e-06	7.71e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	2.98e-06	7.68e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CASP3—malignant glioma	2.97e-06	7.66e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IL2—malignant glioma	2.97e-06	7.65e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—TP53—malignant glioma	2.96e-06	7.62e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—PIK3CA—malignant glioma	2.95e-06	7.59e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	2.94e-06	7.58e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—VEGFA—malignant glioma	2.92e-06	7.52e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—VEGFA—malignant glioma	2.91e-06	7.48e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—TP53—malignant glioma	2.9e-06	7.46e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—STAT3—malignant glioma	2.89e-06	7.45e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—KRAS—malignant glioma	2.89e-06	7.44e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—STAT3—malignant glioma	2.88e-06	7.41e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MMP9—malignant glioma	2.86e-06	7.36e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—TP53—malignant glioma	2.85e-06	7.34e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—KRAS—malignant glioma	2.85e-06	7.34e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—KRAS—malignant glioma	2.85e-06	7.34e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—PTEN—malignant glioma	2.84e-06	7.31e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	2.83e-06	7.28e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—VEGFA—malignant glioma	2.83e-06	7.28e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—PIK3CA—malignant glioma	2.81e-06	7.25e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MMP9—malignant glioma	2.81e-06	7.24e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—STAT3—malignant glioma	2.8e-06	7.21e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—PTEN—malignant glioma	2.79e-06	7.2e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MYC—malignant glioma	2.78e-06	7.17e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—VEGFA—malignant glioma	2.78e-06	7.16e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—AKT1—malignant glioma	2.77e-06	7.13e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—STAT3—malignant glioma	2.75e-06	7.09e-05	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	2.73e-06	7.03e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—AKT1—malignant glioma	2.73e-06	7.02e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—EGFR—malignant glioma	2.72e-06	7.01e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—TP53—malignant glioma	2.72e-06	7.01e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CASP3—malignant glioma	2.7e-06	6.97e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IL2—malignant glioma	2.7e-06	6.96e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MYC—malignant glioma	2.69e-06	6.92e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MYC—malignant glioma	2.67e-06	6.89e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—PIK3CA—malignant glioma	2.65e-06	6.83e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—PIK3CA—malignant glioma	2.64e-06	6.8e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—EGFR—malignant glioma	2.63e-06	6.77e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—PIK3CA—malignant glioma	2.62e-06	6.74e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—PIK3CA—malignant glioma	2.62e-06	6.74e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—EGFR—malignant glioma	2.61e-06	6.74e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MYC—malignant glioma	2.6e-06	6.7e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—KRAS—malignant glioma	2.57e-06	6.63e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—TP53—malignant glioma	2.57e-06	6.61e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—VEGFA—malignant glioma	2.56e-06	6.6e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MYC—malignant glioma	2.56e-06	6.59e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MMP9—malignant glioma	2.56e-06	6.58e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—EGFR—malignant glioma	2.54e-06	6.55e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PTEN—malignant glioma	2.54e-06	6.55e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—STAT3—malignant glioma	2.54e-06	6.54e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—TP53—malignant glioma	2.53e-06	6.52e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—TP53—malignant glioma	2.53e-06	6.52e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—VEGFA—malignant glioma	2.52e-06	6.5e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—EGFR—malignant glioma	2.5e-06	6.45e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—AKT1—malignant glioma	2.5e-06	6.44e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—STAT3—malignant glioma	2.5e-06	6.44e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—KRAS—malignant glioma	2.48e-06	6.4e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	2.48e-06	6.39e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—KRAS—malignant glioma	2.47e-06	6.36e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—AKT1—malignant glioma	2.45e-06	6.3e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—AKT1—malignant glioma	2.41e-06	6.2e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—KRAS—malignant glioma	2.4e-06	6.19e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—KRAS—malignant glioma	2.36e-06	6.09e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—PIK3CA—malignant glioma	2.36e-06	6.09e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MYC—malignant glioma	2.36e-06	6.08e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MYC—malignant glioma	2.32e-06	5.98e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—EGFR—malignant glioma	2.31e-06	5.94e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—AKT1—malignant glioma	2.3e-06	5.92e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	2.3e-06	5.91e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—TP53—malignant glioma	2.29e-06	5.89e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	2.28e-06	5.88e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—STAT3—malignant glioma	2.27e-06	5.85e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—EGFR—malignant glioma	2.27e-06	5.85e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	2.27e-06	5.85e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—PIK3CA—malignant glioma	2.21e-06	5.69e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—TP53—malignant glioma	2.21e-06	5.68e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—TP53—malignant glioma	2.2e-06	5.65e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—KRAS—malignant glioma	2.18e-06	5.62e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—PIK3CA—malignant glioma	2.17e-06	5.6e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—AKT1—malignant glioma	2.17e-06	5.58e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—AKT1—malignant glioma	2.16e-06	5.55e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—KRAS—malignant glioma	2.14e-06	5.53e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PIK3CA—malignant glioma	2.14e-06	5.52e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—AKT1—malignant glioma	2.14e-06	5.51e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—AKT1—malignant glioma	2.14e-06	5.51e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—TP53—malignant glioma	2.14e-06	5.5e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MYC—malignant glioma	2.11e-06	5.44e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—TP53—malignant glioma	2.1e-06	5.41e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—EGFR—malignant glioma	2.07e-06	5.32e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—PIK3CA—malignant glioma	2e-06	5.16e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	1.97e-06	5.08e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—KRAS—malignant glioma	1.95e-06	5.03e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—TP53—malignant glioma	1.94e-06	4.99e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—AKT1—malignant glioma	1.93e-06	4.97e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—TP53—malignant glioma	1.91e-06	4.91e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—AKT1—malignant glioma	1.86e-06	4.8e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—AKT1—malignant glioma	1.85e-06	4.78e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—AKT1—malignant glioma	1.8e-06	4.64e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	1.79e-06	4.62e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—AKT1—malignant glioma	1.77e-06	4.57e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—AKT1—malignant glioma	1.75e-06	4.51e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—TP53—malignant glioma	1.73e-06	4.47e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—AKT1—malignant glioma	1.64e-06	4.21e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—AKT1—malignant glioma	1.61e-06	4.15e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—AKT1—malignant glioma	1.46e-06	3.77e-05	CbGpPWpGaD
